Pilot Funding Available for Clinical Trials
Involving Precision Medicine, Outcomes Research, and Team Science
As UTMB’s home for translational research, ITS is working to improve the health of our community through innovation, team science, and the development, application, and evaluation of precision medicine approaches. Currently, we are soliciting applications for pilot funding to support: Clinical Trials in Precision Medicine/Outcomes Research, and New Multidisciplinary Translational Teams.
Precision Medicine is critical to translating discoveries into practice, facilitating delivery of “the right treatment, to the right person, at the right time”. By better understanding how individual differences in biological, environmental, and behavioral factors affect disease, we can customize interventions and improve health outcomes.
Our support of precision medicine and outcomes research pilot projects is aligned with national initiatives of the NIH (http://www.nih.gov/precision-medicine-initiative-cohort-program) and the White House (https://www.whitehouse.gov/blog/2015/01/30/precision-medicine-initiative-data-driven-treatments-unique-your-own-body). Our intention is to facilitate use of large datasets, -omics technologies, and other innovative methods to: identify new diagnostics and targets for prevention and treatment; advance pharmacological studies; and accelerate development of precision approaches.
Multidisciplinary Translational Teams (MTTs) are diverse groups of researchers addressing a variety of important health issues. While each MTT is unique, they have some common elements, including a focus on translational research, and the fact that they are composed of both senior and junior level investigators from multiple disciplines or departments. In conducting their research, MTTs also focus on enhancing collaboration among members and strengthening partnerships with other researchers, industry, and the community. In addition, MTTs build the translational workforce through mentoring and accelerate translation by securing extramural funding for their work and disseminating their findings. Support of MTTs is intended to help investigators be even more effective in conducting collaborative research and mentoring trainees.
To be considered for funding, applications must be received by 5:00pm, February 10, 2017 and
must follow all instructions in the RFAs, available at:
These pilot projects are funded through the Institute’s Clinical and Translational Science Award (CTSA).